Also trades as: BOT.AX (ASX) · $vol 0M
BXPHF OTC
Botanix Pharmaceuticals Limited
1W: +46.8%
1M: -4.8%
3M: +40.4%
YTD: -79.8%
1Y: -88.1%
3Y: -86.6%
5Y: -77.1%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$43.7M
52W Range0.01-0.115
Volume100,000
Avg Volume35,094
Beta0.86
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHowie McKibbon
Employees11
SectorHealthcare
IndustryBiotechnology
IPO Date2019-09-09
Websitebotanixpharma.com
Tower 5, Collins Square
Melbourne, VIC 3008
AU
Melbourne, VIC 3008
AU
61 8 6555 2945
About Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Ltd is a dermatology company that focuses on developing safe and effective topical treatments for serious skin conditions. The company's product pipeline includes treatments for conditions such as moderate to severe acne, atopic dermatitis, rosacea, and axillary hyperhidrosis. It has an exclusive license to use a proprietary drug delivery system for skin diseases.
Latest News
No recent news
Recent Insider Trades
No insider trades found